Avion Wealth Arvinas, Inc. Transaction History

Avion Wealth

$390 Million
Q1 2025

A detailed history of Avion Wealth transactions in Arvinas, Inc. stock. As of the latest transaction made, Avion Wealth holds 33 shares of ARVN stock, worth $214. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Holding current value

$214

% of portfolio

0.0%

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2025 May 09, 2025	BUY	$7.02 - $20.5 $231 - $676	33 New	33 $0
Q4 2023 Jan 26, 2024	BUY	$14.19 - $42.33 $468 - $1,396	33 New	33 $1,000

Others Institutions Holding ARVN

# of Institutions

246

Shares Held

62.5M

Call Options Held

2.65M

Put Options Held

1.1M

Vanguard Group Inc Valley Forge, PA

8.36M
Shares

$54.4 Million
0.0% of portfolio
Black Rock Inc. New York, NY

6.26M
Shares

$40.7 Million
0.0% of portfolio
Ken Griffin Citadel Advisors LLC | Chicago, Il

3.88M
Shares

$25.2 Million
0.01% of portfolio
Price T Rowe Associates Inc Baltimore, MD

3.83M
Shares

$24.9 Million
0.0% of portfolio
Rtw Investments, LP New York, NY

3.33M
Shares

$21.7 Million
0.38% of portfolio

View Full List

About ARVINAS, INC.

Ticker ARVN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,205,300
Market Cap $346M
Description
Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...

More about ARVN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Avion Wealth, based on Form 13F filings with the SEC.

News

Stay updated on Avion Wealth with notifications on news.

Account